In addition to an annual flu shot, University Health Center recommends the following immunizations:
Hepatitis A (HAV)
Hepatitis A is a serious liver disease caused by a virus. Hepatitis A is found in the stool of an infected person. It is typically spread by close personal contact and by eating contaminated food or drinking contaminated water. The vaccine is commonly recommended for travel but is also widely given as a routine immunization. It is a series of 2 injections given over a 6-12 month period of time.
Hepatitis B (HBV)
Hepatitis B is a serious viral infection of the liver. Some people with acute infection go on to develop chronic hepatitis B, which can lead to liver damage and liver cancer. In adults, the disease is transmitted most commonly through sexual activity, but it can also be transmitted through any infected blood or bodily fluids. The virus is virulent (hard to kill) and even lives in dried secretions on inanimate objects up to seven days. The virus is 100 times more infectious than HIV.
There is a vaccine to protect against the hepatitis B virus. It is commonly recommended for travel but it is also widely given as a routine immunization. The vaccine series is 3 injections which are typically spread over 6 months. There is also an option of an accelerated administration schedule.
Human Papillomavirus (HPV)
Human Papillomavirus (HPV) is the most common sexually transmitted virus in the US. It causes genital warts and cervical cancer as well as other cancers of the genital tract, anus and throat.
There are two vaccines approved by the FDA: Gardasil and Cervarix. The UHC recommends and stocks only the Gardasil vaccine as it provides broader coverage than Cervarix. Gardasil protects against 4 major strains of HPV. It is recommended for both females and males ages 9 through 26. The vaccine series consists of 3 injections that are given over a 6-month period of time.
Students may be eligible to receive the vaccine at a reduced cost. For more information, please contact the Nurse Specialty Clinic at 541-346-2739.
Meningitis Type B
Meningitis disease is a rare but serious infection caused by either bacteria or a virus. The disease is typically transmitted via air droplets of respiratory secretions, direct contact with an infected person, or sharing items such as cigarettes or drinking glasses.
The Meningitis B vaccine was approved by the CDC for limited use (by currently-enrolled UO undergraduate students and those in high-risk populations) to prevent the spread of meningococcal disease during the 2015 outbreak. There are 2 Type B vaccines approved by the Food and Drug Administration (FDA) in 2014 and 2015:
- Trumenba® is approved for use in people 10-25 years of age as a 3-dose series.
- Bexsero® is approved for use in people 10-25 years of age as a 2-dose series.
Meningitis FAQs here
Records drop-off locations in the Health Center:
Reception desk on first floor
After-hours drop box (outside 13th Street entrance)
1232 University of Oregon Eugene OR 97403-1232
ATTENTION: Measles / Mumps Compliance
page updated 6/09/2017